Plunkett Research Online: Anthera Pharmaceuticals Inc

ANTHERA PHARMACEUTICALS INC (ANTH:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anthera Pharmaceuticals Inc. is a biopharmaceutical company focusing on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company has one Phase 2 clinical program, blisibimod. Two of its product candi.....



Anthera Pharmaceuticals Inc
Ticker: ANTH
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 856-5600
Fax:
Address: 25801 Industrial Boulevard
Suite B
Hayward, CA 94545 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs (Pharmaceuticals), Discovery & Manufacturing
ContactsDescription
Paul TruexChairman of the Board/Director
May LiuChief Accounting Officer/Senior VP, Divisional
See More
Anthera Pharmaceuticals Inc. is a biopharmaceutical company focusing on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company has one Phase 2 clinical program, blisibimod. Two of its product candi.....See More See More

Auditor: BDO USA, LLP
Legal Advisor: Goodwin Procter LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: